ads

Ozempic Is About to Go Generic in India, China and Canada

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.

from NYT > World > Americas https://ift.tt/p9SBg6K

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.